Skip to main content
OpenTrials
Completed

NCT Number: NCT06490497

Expectations and Needs of a Glioblastoma Caregiver

Cancers of the central nervous system have a poor prognosis. Glioblastoma is most common glial tumor of the central nervous system. The presence of a tumour in the brain determines the particular and specific nature of care for these patients and their families. Symptoms affect daily life and the balance of the family sphere.It's easy to imagine a difficult and disturbed family's daily routine.

Caregivers find themselves in great distress but can still benefit from support to lighten the domestic burden, and financial burden, thanks to the various recommendations of successive Cancer Plans. In fact, support for patients and their families during the illness and after is one of the key points of the programs in place. The aim of this research will be to provide food for thought in order to improve the support provided to family and friends.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hôpital Nord Franche-Comté

Trévenans, 90400, France

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Caregivers of a person with glioblastoma glioblastoma undergoing oncology treatment
  • Caregivers aged 18 and over

Exclusion criteria

  • Patient's opposition to participating in the study

Treatment and study plan

interview

Other

individual interviews semi-directive

Primary outcomes

  1. Difficulties and specific needs of a caregiver

    Time frame: Day 1

    Identify the difficulties and specific needs of a caregiver in the particular context of a person with glioblastoma.

Sponsors and collaborators

Lead sponsor

Hopital Nord Franche-Comte

Other

Registry information

Official study title

Analysis of the Expectations and Needs of a Caregiver of a Glioblastoma Patient Undergoing in Oncology

Acronym: GLOIOS

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Jul 8, 2024
Registry last updated
Jul 8, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.